SCHEMBL23760112

SCHEMBL23760112

CC(C)(C)OC(=O)N(C(=O)OC(C)(C)C)[C@@H](CCCI)C(=O)OCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TPSAB1 Q15661 2/20 0.46
TPSD1 Q9BZJ3 2/20 0.46
TPSG1 Q9NRR2 2/20 0.46
L3MBTL1 Q9Y468 4/20 0.44
SYK P43405 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
AKT1 P31749 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.39
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
FOLH1 Q04609 1/20 0.38
LTA4H P09960 1/20 0.38
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
NCOR2 Q9Y618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14743381 0.94 TPSAB1 (0.43) TPSAB1TPSD1TPSG1L3MBTL1SYK
SCHEMBL23760082 0.90 TPSAB1 (0.46) TPSAB1TPSD1TPSG1L3MBTL1SYK
SCHEMBL17369155 0.89 TPSAB1 (0.47) TPSAB1TPSD1TPSG1L3MBTL1SYK
SCHEMBL17369165 0.89 TPSAB1 (0.45) TPSAB1TPSD1TPSG1L3MBTL1SYK
SCHEMBL17369164 0.88 SYK (0.46) TPSAB1TPSD1TPSG1L3MBTL1SYK
SCHEMBL14744316 0.88 TPSAB1 (0.43) TPSAB1TPSD1TPSG1L3MBTL1SYK
SCHEMBL5970440 0.87 TPSAB1 (0.44) TPSAB1TPSD1TPSG1L3MBTL1SYK
SCHEMBL8312996 0.87 TPSAB1 (0.48) TPSAB1TPSD1TPSG1L3MBTL1SYK
SCHEMBL12873853 0.85 L3MBTL1 (0.44) TPSAB1TPSD1TPSG1L3MBTL1SYK
SCHEMBL16284728 0.85 SYK (0.50) TPSAB1TPSD1TPSG1L3MBTL1SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230138393-A1 LINKING AMINO ACID SEQUENCES, MANUFACTURING METHOD THEREOF, AND USE THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-05-04 US disclosed
WO-2021163467-A1 LINKING AMINO ACID SEQUENCES, MANUFACTURING METHOD THEREOF, AND USE THEREOF TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2021-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230138393-A1 LINKING AMINO ACID SEQUENCES, MANUFACTURING METHOD THEREOF, AND USE THEREOF BCAT2, BCAT1, AARS1 TPSAB1 4276/4885TPSD1 4714/4885TPSG1 3829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.